Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Pharmacogenomics
|
October 16, 2008
Shifting paradigms in the pharmacogenetics of warfarin
Eva Gak, Hillel Halkin
Parkinsonism & Related Disorders
|
February 5, 2011
Benign hereditary chorea: an update
Rivka Inzelberg, Moran Weinberger, Eva Gak
Pharmacogenomics
|
December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal
Daniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Blood
|
March 26, 2008
VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals
Eleni Aklillu, Cheryl Leong, Ronen Loebstein, et al.
Epigenetics
|
January 23, 2010
MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro
Manuela Vecsler, Amos J Simon, Ninette Amariglio, et al.
Epilepsia
|
May 25, 2010
Epilepsy in Rett syndrome---the experience of a National Rett Center
Andreea Nissenkorn, Eva Gak, Manuela Vecsler, et al.
Thrombosis and Haemostasis
|
February 24, 2006
Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin
Manuela Vecsler, Ronen Loebstein, Shlomo Almog, et al.
Clinical Pharmacology and Therapeutics
|
May 19, 2005
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9
Ronen Loebstein, Manuela Vecsler, Daniel Kurnik, et al.
Human Genetics
|
September 1, 2005
Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis
Liron Abuhatzira, Kirill Makedonski, Yael Petel Galil, et al.
Psychiatric Genetics
|
September 10, 2003
Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis
Michael Ritsner, Sharon Amir, Maya Koronyo-Hamaoui, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Pharmacogenomics
|
October 16, 2008
Shifting paradigms in the pharmacogenetics of warfarin
Eva Gak, Hillel Halkin
Parkinsonism & Related Disorders
|
February 5, 2011
Benign hereditary chorea: an update
Rivka Inzelberg, Moran Weinberger, Eva Gak
Pharmacogenomics
|
December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal
Daniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Blood
|
March 26, 2008
VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals
Eleni Aklillu, Cheryl Leong, Ronen Loebstein, et al.
Epigenetics
|
January 23, 2010
MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro
Manuela Vecsler, Amos J Simon, Ninette Amariglio, et al.
Epilepsia
|
May 25, 2010
Epilepsy in Rett syndrome---the experience of a National Rett Center
Andreea Nissenkorn, Eva Gak, Manuela Vecsler, et al.
Thrombosis and Haemostasis
|
February 24, 2006
Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin
Manuela Vecsler, Ronen Loebstein, Shlomo Almog, et al.
Clinical Pharmacology and Therapeutics
|
May 19, 2005
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9
Ronen Loebstein, Manuela Vecsler, Daniel Kurnik, et al.
Human Genetics
|
September 1, 2005
Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis
Liron Abuhatzira, Kirill Makedonski, Yael Petel Galil, et al.
Psychiatric Genetics
|
September 10, 2003
Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis
Michael Ritsner, Sharon Amir, Maya Koronyo-Hamaoui, et al.
Page
of 2